NAT2 Genotype
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Isoniazid Dosage Prediction Model Development (NCT02747654) | Samsung Medical Center | 2014-06-01 |
Track NAT2 Genotype automatically
Every clearance here is in the API, with alerts when new ones post.